← All diseases
Heart and blood vessels
Cardiac amyloidosis
Would you like to receive a message when there is new research about cardiac amyloidosis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a single sentence appears above each publication explaining what was investigated — and you'll receive a notification as soon as new research on Cardiac Amyloidosis is available. View what Premium costs.
Publications and studies (1413)
- Limited duration of dexamethasone in newly diagnosed AL amyloidosis: impact on response, toxicity, and survival. (2026/12/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Septal thickness to QRS voltage ratio in Lead I/aVR: A simple tool for estimating cardiac amyloid burden. (2026/10/15) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Amyloid-Like Immunoglobulin Deposition Neuropathy. (2026/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Transthyretin Amyloid Cardiomyopathy in Women: Epidemiology, Diagnostic Delay, and Clinical Implications. (2026/08/10) ♡
- Outcomes of living related kidney donors of recipients with familial mediterranean fever-associated Amyloid A Amyloidosis. (2026/08/07) ♡
- Analysis of serum NMR metabolomics in fibrotic diseases of the myocardium. (2026/08/07) ♡
- Utility of Prognostic Staging Systems in Transthyretin Amyloidosis Cardiomyopathy in the Era of Available Disease-Modifying Treatment. (2026/08/07) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Cardiac Tamponade From Lymphocytic Constrictive Pericarditis in Primary AL Amyloidosis Without Myocardial Involvement. (2026/08/06) ♡
- Arterial-myocardial coupling in primary light chain amyloidosis: A prospective observational study of vascular involvement. (2026/08/06) ♡
- Comorbidity Burden in Transthyretin Amyloidosis With Cardiomyopathy: Insights From the HELIOS-B Trial. (2026/08/06) ♡
- Effect of acoramidis on risk of death and heart problem-related hospitalizations in people with transthyretin amyloid cardiomyopathy: a plain language summary. (2026/08/05) ♡
- Health Care Resource Utilization in Transthyretin Amyloid Cardiomyopathy Compared With Non-amyloid Heart Failure and the General Population. (2026/08/04) ♡
- Temporal shifts in diagnostic testing for cardiac amyloidosis across U.S. health systems. (2026/08/03) ♡
- Role of FibroScan in evaluating hepatic involvement in systemic amyloidosis: a single-centre prospective pilot study. (2026/08/03) ♡
- Prevalence and Determinants of Asymmetric Septal Hypertrophy (ASH) in Diseases of Left Ventricular Hypertrophy (LVH). (2026/08/03) ♡
- Plain language summary of how acoramidis affects the total number of heart problems over time in people with ATTR-CM: findings from the ATTRibute-CM study. (2026/08/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cardiovascular Care in Multiple Myeloma: A Comprehensive Review and Integrated Systems-Based Approach from a UK Cardio-Oncology Centre of Excellence. (2026/08/03) ♡
- Triple amyloidosis involving fibrinogen Aα-chain, apolipoprotein A-I and EGF-containing fibulin-like matrix protein 1 in an aged dog. (2026/08/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Efficacy and tolerability of sodium-glucose cotransporter-2 inhibitors in transthyretin amyloid cardiomyopathy: A systematic review and stratified meta-analysis. (2026/08/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Atrial Fibrillation in Transthyretin Amyloid Cardiomyopathy: Mechanisms, Prognostic Implications, and Management. (2026/08/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Laboratory investigations to rule out AL amyloidosis: practical guidance for the cardiologist]. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Multidimensional care in transthyretin cardiac amyloidosis: Integrating extracardiac organ involvement and comorbidity management. (2026/08/01) ♡
- Human islet amyloid polypeptide aggregation upregulates the mitochondrial cholesterol transport protein StAR and induces mitochondrial dysfunction in beta cells. (2026/08/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Cardiac Amyloidosis in Asia: What We Know and Don't Know. (2026/08/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Diagnosing Transthyretin Cardiac Amyloidosis in Japan: Lessons From J-COSSA on Access, Equity, and Earlier Detection. (2026/08/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Beyond Wall Thickness: Phenotype-Guided Diagnosis of Left Ventricular Hypertrophy. (2026/08/01) ♡
- Rationale and Design of ACO-REAL: A Real-World Non-Interventional Study of Acoramidis in Routine Clinical Practice. (2026/07/31) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Wild-Type Transthyretin Amyloid Cardiomyopathy With Positive (18)F-FDG/(13)N-Ammonia Cardiac Positron Emission Tomography. (2026/07/31) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Myocardial remodeling in valvular heart disease: pathophysiology, multimodality imaging and treatment implications. (2026/07/30) ♡
- A rigorous standardized uptake value-based framework for monitoring tafamidis response in transthyretin cardiac amyloidosis with bone-avid single-photon emission computed tomography/computed tomography. (2026/07/30) ♡
- Diagnostic utility of deep excisional skin biopsy including abdominal fat for transthyretin cardiac amyloidosis. (2026/07/30) ♡
- Contemporary Real-World Treatment of Cardiac Transthyretin Amyloidosis with Tafamidis: A Long-Term Multicentre Study. (2026/07/30) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Anakinra for intravenous immunoglobulin-resistant Kawasaki disease: a systematic literature review. (2026/07/30) ♡
- The severity of harm score database: an evidence-based foundation for laboratory test risk analysis. (2026/07/29) ♡
- Effect of Acoramidis on Heart Failure-Related Health Status: A Secondary Analysis of the ATTRibute-CM Randomized Clinical Trial. (2026/07/29) ♡
- Sex Differences in Presentation and Outcomes of Transthyretin Amyloid Cardiomyopathy. (2026/07/28) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Transjugular Tricuspid Valve Edge-to-Edge Repair. (2026/07/25) ♡
- Sex Differences in Phenotype and Tafamidis-Associated Survival in Val122Ile Transthyretin Cardiac Amyloidosis. (2026/07/25) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. AL Cardiac Amyloidosis in Resource-Limited Settings: Diagnostic Challenges and Therapeutic Gaps. (2026/07/25) ♡
- Pathology-Based Validation of Quantitative SPECT/CT in Patients With Suspected Transthyretin Amyloid Cardiomyopathy. (2026/07/23) ♡
- A novel method to classify exercise response in patients with cardiac amyloidosis - The RoMa classification. (2026/07/23) ♡
- Cardiovascular Imaging with Total Body PET. (2026/07/23) ♡
- High CA125 levels as a red flag for ATTR Cardiac Amyloidosis. (2026/07/22) ♡
- Automated identification of cardiac amyloidosis using cross-modal neural networks on [Formula: see text]-Pyrophosphate SPECT imaging and clinical data. (2026/07/22) ♡
- Delayed Diagnosis of Transthyretin Cardiac Amyloidosis Is Associated With Heart Failure Hospitalizations and Mortality. (2026/07/22) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. From diagnosis to quantification of amyloid burden: Reappraising the wall thickness-to-voltage ratio in cardiac amyloidosis. (2026/07/22) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Five-year follow-up of leptomeningeal transthyretin amyloidosis (Ala45Thr) with CNS involvement under tolcapone therapy. (2026/07/22) ♡
- Identifying implementation strategies to increase the early detection of cardiac amyloidosis: a pre-implementation study. (2026/07/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Expert Consensus and Clinical Pathway Recommendations for Transthyretin Amyloid Cardiomyopathy in Malaysia. (2026/07/22) ♡
- Sex based differences in clinical outcomes among heart failure patients with cardiac amyloidosis on sodium glucose Co-transporter-2 inhibitor therapy: A propensity score-matched analysis. (2026/07/21) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.